secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innovation1 Biotech Inc. (—)
CIK:        0001629205
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0001477932-23-009118
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Innovation1 Biotech raises $150k via secured convertible notes and warrants
---------------------------------------------------------------------------

- Gross proceeds of $150,000 from $176,472 principal notes at 8% interest, mature Jan 6, 2025.
- 2,205,882 common stock purchase warrants issued at exercise price of $0.08 per share.
- Notes convertible into common stock at $0.08 per share, with 4.99% beneficial ownership limit.
- Transaction exempt from registration under Rule 506(b) of Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1629205/000147793223009118/0001477932-23-009118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1629205/000147793223009118/ivbt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-009118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer